Zafirlukast (Accolate): A new treatment for capsular contracture.
Aesthet Surg J
; 22(4): 329-36, 2002 Jul.
Article
em En
| MEDLINE
| ID: mdl-19331987
ABSTRACT
BACKGROUND:
Capsular contracture after breast augmentation or reconstructive breast surgery is a difficult problem. Previous studies have suggested that alteration of the inflammatory response could have a role in reducing the incidence of capsular contracture.OBJECTIVE:
We report a series of patients with Baker class III or IV capsular contracture who underwent treatment with zafirlukast.METHODS:
Patients received a regimen of zafirlukast 20 mg by mouth 2 times daily for 3 months.RESULTS:
In many cases, dramatic softening of the breast capsule was evident after 1 to 3 months of treatment.CONCLUSIONS:
Zafirlukast appears to effectively soften early capsular contracture and may prevent the formation of capsular contracture in those patients at risk. (Aesthetic Surg J 2002;22329-336.).
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Aesthet Surg J
Ano de publicação:
2002
Tipo de documento:
Article